[go: up one dir, main page]

FI833839A7 - Foerfarande foer framstaellning av terapeutiskt aktiva kefalosporinderivat - Google Patents

Foerfarande foer framstaellning av terapeutiskt aktiva kefalosporinderivat

Info

Publication number
FI833839A7
FI833839A7 FI833839A FI833839A FI833839A7 FI 833839 A7 FI833839 A7 FI 833839A7 FI 833839 A FI833839 A FI 833839A FI 833839 A FI833839 A FI 833839A FI 833839 A7 FI833839 A7 FI 833839A7
Authority
FI
Finland
Prior art keywords
kefalosporinderivat
foerfarande foer
foer framstaellning
aktiva
terapeutiskt
Prior art date
Application number
FI833839A
Other languages
English (en)
Other versions
FI75348C (fi
FI75348B (fi
FI833839A0 (fi
Inventor
Nobuharu Kakeya
Susumu Nishizawa
Satoshi Tamaki
Kazuhiko Kitao
Original Assignee
Kyoto Pharma Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyoto Pharma Ind filed Critical Kyoto Pharma Ind
Publication of FI833839A0 publication Critical patent/FI833839A0/fi
Publication of FI833839A7 publication Critical patent/FI833839A7/fi
Application granted granted Critical
Publication of FI75348B publication Critical patent/FI75348B/fi
Publication of FI75348C publication Critical patent/FI75348C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36Methylene radicals, substituted by sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B60VEHICLES IN GENERAL
    • B60JWINDOWS, WINDSCREENS, NON-FIXED ROOFS, DOORS, OR SIMILAR DEVICES FOR VEHICLES; REMOVABLE EXTERNAL PROTECTIVE COVERINGS SPECIALLY ADAPTED FOR VEHICLES
    • B60J10/00Sealing arrangements
    • B60J10/20Sealing arrangements characterised by the shape
    • B60J10/24Sealing arrangements characterised by the shape having tubular parts
    • B60J10/248Sealing arrangements characterised by the shape having tubular parts having two or more tubular cavities, e.g. formed by partition walls
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B60VEHICLES IN GENERAL
    • B60JWINDOWS, WINDSCREENS, NON-FIXED ROOFS, DOORS, OR SIMILAR DEVICES FOR VEHICLES; REMOVABLE EXTERNAL PROTECTIVE COVERINGS SPECIALLY ADAPTED FOR VEHICLES
    • B60J10/00Sealing arrangements
    • B60J10/80Sealing arrangements specially adapted for opening panels, e.g. doors
    • B60J10/86Sealing arrangements specially adapted for opening panels, e.g. doors arranged on the opening panel
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Mechanical Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Removal Of Floating Material (AREA)
  • Measurement Of Force In General (AREA)
  • Train Traffic Observation, Control, And Security (AREA)
FI833839A 1982-11-10 1983-10-20 Foerfarande foer framstaellning av terapeutiskt anvaendbart 7-mandelamid-3-cefem-4-karboxylatderivat. FI75348C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP8200437 1982-11-10
PCT/JP1982/000437 WO1984001949A1 (fr) 1982-11-10 1982-11-10 Derives de cephalosporine, leur procede de preparation et agent prophylactique de traitement contre les infections bacteriennes

Publications (4)

Publication Number Publication Date
FI833839A0 FI833839A0 (fi) 1983-10-20
FI833839A7 true FI833839A7 (fi) 1984-05-11
FI75348B FI75348B (fi) 1988-02-29
FI75348C FI75348C (fi) 1988-06-09

Family

ID=13762361

Family Applications (1)

Application Number Title Priority Date Filing Date
FI833839A FI75348C (fi) 1982-11-10 1983-10-20 Foerfarande foer framstaellning av terapeutiskt anvaendbart 7-mandelamid-3-cefem-4-karboxylatderivat.

Country Status (18)

Country Link
US (1) US4605651A (fi)
EP (1) EP0108942B1 (fi)
JP (1) JPS59116292A (fi)
KR (1) KR900007200B1 (fi)
AT (1) ATE32724T1 (fi)
AU (1) AU568094B2 (fi)
CA (1) CA1239928A (fi)
CY (1) CY1512A (fi)
DE (1) DE3375787D1 (fi)
DK (1) DK481883A (fi)
ES (3) ES8504821A1 (fi)
FI (1) FI75348C (fi)
HK (1) HK39390A (fi)
NO (1) NO162240C (fi)
NZ (1) NZ206019A (fi)
SU (2) SU1322983A3 (fi)
WO (1) WO1984001949A1 (fi)
ZA (1) ZA837635B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6034978A (ja) * 1984-03-29 1985-02-22 Kyoto Yakuhin Kogyo Kk セフアロスポリン誘導体およびその製造方法
JPS6034975A (ja) * 1984-03-29 1985-02-22 Kyoto Yakuhin Kogyo Kk セフアロスポリンの製造方法
DK401088A (da) * 1987-07-21 1989-01-22 Kyoto Pharma Ind Cephalosporinforbindelse, fremgangsmaade til fremstilling deraf og farmaceutisk praeparat indeholdende den
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
JP4323968B2 (ja) * 2004-01-14 2009-09-02 株式会社日立コミュニケーションテクノロジー 無線通信装置のタイミング調整方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1229453A (fi) * 1968-01-30 1971-04-21
US3701775A (en) * 1970-11-25 1972-10-31 Smith Kline French Lab Esters of mandeloylaminocephalosporanic acids
IL38099A (en) * 1970-12-17 1976-01-30 Smith Kline French Lab 3-heterocyclyl thiomethylcephalosporins
US3812116A (en) * 1971-07-02 1974-05-21 Fujisawa Pharmaceutical Co 7-acylated 3-substituted cephalosporin compounds
GB1425933A (en) * 1972-03-13 1976-02-25 Astra Laekemedel Ab Cephalosporins
US4107433A (en) * 1974-02-21 1978-08-15 Beecham Group Limited Phthalidyl ester of 3-carbomoyloxy cephalosporin derivatives
GB1492393A (en) * 1974-02-21 1977-11-16 Beecham Group Ltd Cephalosporin esters
CH606001A5 (fi) * 1974-05-13 1978-10-13 Ciba Geigy Ag
US3933808A (en) * 1974-05-20 1976-01-20 Eli Lilly And Company Cephalosporin esters
US4172196A (en) * 1974-09-03 1979-10-23 Bristol-Myers Company Certain 7-α-substituted-α-hydroxyacetamido-3-(1-carboxymethyltetrazol-5-yl-thiomethyl)-3-cephem-4-carboxylic acids
JPS5283877A (en) * 1976-01-01 1977-07-13 Lilly Co Eli Cephalospoline esters
MA18686A1 (fr) * 1978-07-07 1980-10-01 Ciba Geigy Ag Composes aminothiazoliques
JPS57193489A (en) * 1981-05-21 1982-11-27 Fujisawa Pharmaceut Co Ltd Syn-isomer of 7-substituted-3-cephem-4-carboxylic acid ester and its preparation

Also Published As

Publication number Publication date
DK481883A (da) 1984-05-11
CA1239928A (en) 1988-08-02
NZ206019A (en) 1986-06-11
ES526561A0 (es) 1985-04-16
HK39390A (en) 1990-06-01
DK481883D0 (da) 1983-10-20
ES532996A0 (es) 1985-08-16
AU2019983A (en) 1984-05-17
WO1984001949A1 (fr) 1984-05-24
ES532997A0 (es) 1985-08-16
KR840006667A (ko) 1984-12-01
ZA837635B (en) 1984-11-28
SU1322983A3 (ru) 1987-07-07
JPS59116292A (ja) 1984-07-05
DE3375787D1 (en) 1988-04-07
CY1512A (en) 1990-08-03
EP0108942A2 (en) 1984-05-23
KR900007200B1 (ko) 1990-10-05
SU1309912A3 (ru) 1987-05-07
ES8507151A1 (es) 1985-08-16
ATE32724T1 (de) 1988-03-15
EP0108942A3 (en) 1985-05-15
FI75348C (fi) 1988-06-09
NO833807L (no) 1984-05-11
ES8507150A1 (es) 1985-08-16
AU568094B2 (en) 1987-12-17
NO162240C (no) 1989-11-29
FI75348B (fi) 1988-02-29
FI833839A0 (fi) 1983-10-20
US4605651A (en) 1986-08-12
NO162240B (no) 1989-08-21
EP0108942B1 (en) 1988-03-02
ES8504821A1 (es) 1985-04-16

Similar Documents

Publication Publication Date Title
FI830190L (fi) Foerfarande foer framstaellning av monokloniska maenniskoantikroppar
FI832803L (fi) Foerfarande foer framstaellning av hartsimpregnerade fiberkompositmaterial
FI834804A0 (fi) Av cellulosafyllning innehaollande etyleninterpolymerer framstaellda traelika foeremaol
FI832035L (fi) Foerfarande foer framstaellning av indolderivat
FI833295L (fi) Elektronisk hoegfrekvensstyrd anordning foer styrning av gasurladdningslampor
FI834397A0 (fi) Lindning av cellulosabanor
FI830288A0 (fi) Foerfarande foer behandling av kemiska pappersmassor
FI833874L (fi) Anordning foer maetning av sedimenteringsgrad av roeda blodceller
FI824482A0 (fi) Foerfarande foer foerstaerkning av fibervaevnader medelst vattenhaltiga plastdispersioner
FI840599A0 (fi) Vakuumklaemtruck foer behandling av pappersrullar
FI832974A7 (fi) Anordning foer separering av avfallsprodukter fraon fluidum- och gasstroem
FI834231A0 (fi) Enzymatisk syntes av l-serin
FI64260B (fi) Anordning foer foerdelning av en stroemning
FI832817A0 (fi) Foerfarande foer framstaellning av alfaarylalkanosyror
FI830307L (fi) Disproportionering av omaettade syror
FI832990L (fi) Foerfarande foer framstaellning av en diagnostisk anordning
FI832404A0 (fi) Foerbaettrat foerfarande foer isomerisering av glukos
FI832403L (fi) Foerfarande foer isomerisering av glukos
FI831535L (fi) Reaktor foer framstaellning av klordioxid
FI830891A0 (fi) Foerfarande foer framstaellning av pyridinderivat
FI831783L (fi) Foerfarande foer framstaellning av en skida
FI823477A0 (fi) Kondensering av zinkaonga
FI832631A7 (fi) Foerfarande foer framstaellning av papper
FI834521A0 (fi) Foerfarande foer bekaempning av svampinfektioner
FI833839A7 (fi) Foerfarande foer framstaellning av terapeutiskt aktiva kefalosporinderivat

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: KYOTO PHARMACEUTICAL INDUSTRIES, LTD.